In 2026, schweizeraktien.net will host the «HealthCare Investors Meeting» (HCIM) for the first time in partnership with the AEVIS Victoria Group and AGEFI. The conference will bring together investors, analysts, and representatives of leading Swiss-listed small and medium-sized enterprises (SMEs) from the medtech and pharmaceutical sectors. The aim is to strengthen the dialogue between the capital markets and innovative healthcare companies – at a venue that itself symbolizes progress: the Genolier Innovation Hub.
date & time
31/03/2026, 10 am to 5 pm
place
Genolier Innovation Hub, Route du Muids 3
1272 Genolier, Switzerland
focus
swiss listed heathcare & life sciences companies (small & medium companies)
participating companies
AEVIS Victoria, Basilea, BioVersys, Galenica, Polypeptide and scale-ups in a «private track»
target group
Private & institutional investors, company executives
Registration
If you would like to participate, please fill out the application form.
Companies listed on the SIX Swiss Exchange in the Life Sciences or Healthcare sectors (small & mid caps) are invited to apply for an investors presentation at the Healthcare Investors Meeting on 31st march 2026. The final selection will be made by the Steering Committee of schweizeraktien.net, AEVIS Victoria, and AGEFI.
For further details, pls. contact hcim@schweizeraktien.net
